Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03858972 |
|---|---|
| Brief Title: | Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC (CONTESSA 2) |
| First Submitted : | February 26, 2019 |
| First Submitted that Met QC Criteria : | February 28, 2019 |
| First Posted : | March 1, 2019 |
| Last Update Submitted that Met QC Criteria : | July 26, 2021 |
| Last Update Posted : | July 30, 2021 |